[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
England and Wales High Court (Patents Court) Decisions |
||
You are here: BAILII >> Databases >> England and Wales High Court (Patents Court) Decisions >> Illumina, Inc ("Illumina") & Ors v Illumina, Inc & Ors [2016] EWHC 3345 (Pat) (16 December 2016) URL: http://www.bailii.org/ew/cases/EWHC/Patents/2016/3345.html Cite as: [2016] EWHC 3345 (Pat) |
[New search] [Printable RTF version] [Help]
CHANCERY DIVISION
PATENTS COURT
7 Rolls Building Fetter Lane London EC4A 1NL |
||
B e f o r e :
____________________
(1) ILLUMINA, INC. ("Illumina") (2) VERINATA HEALTH INC (3) SEQUENOM INC ("Sequenom") (4) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Claimants in Claim No. HC-2015-001175) |
Claimants |
|
- and - |
||
(1) ILLUMINA, INC. (2) THE CHINESE UNIVERSITY OF HONG KONG (Claimants in Claim No. HP-2015-000047) |
Claimants |
|
- and - |
||
PREMAITHA HEALTH PLC (Defendant in Claims Nos. HP-2015-000047 and HP-2015-001175) |
Defendant |
____________________
for the Claimants
Mr Daviel Beard QC and Ms Ligia Osepciu (instructed by Allen & Overy LLP)
for the Defendant
____________________
Crown Copyright ©
MR. JUSTICE ROTH:
"(i) The collateral purpose rule now contained in CPR 31.22 exists for sound and long established policy reasons. The court will only grant permission under 31.22(1)(b) if there are special circumstances which constitute a cogent reason for permitting collateral use.
…
(iii) There is a strong public interest in facilitating the just resolution of civil litigation. Whether that public interest warrants releasing a party from the collateral purpose rule depends upon the particular circumstances of the case. Those circumstances require careful examination. There are decisions going both ways in the authorities cited above.